Maryland Oncology Hematology

Annapolis, Maryland 21401

2 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Cancer, Early Detection of Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, SARS-CoV-2 Infection, Uterine Serous Carcinoma

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
• PATHFINDER 2: A Multi-Cancer Early Detection Study — Running, not enrolling
• A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma — Completed
• Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2 — Stopped early